Status: Recruiting
REpeat Intervention For Failed Surgical BioProsthEtic AorTic Valves (REPEAT)
The overall hypothesis is that redo aortic valve replacement (rAVR) is superior to valve-invalve transcatheter aortic valve replacement (ViV-TAVR) for the composite endpoint of freedom from all-cause mortality, all-cause stroke, myocardial infarction, and rehospitalization for heart failure or aortic valve re-intervention at 5 years.
Participants needed: 890
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Heart Center Leipzig - University HospitalUpdated: Mar 10, 2026Locations: 1
Eligibility criteria
Indication for repeat intervention for failed surgical aortic bioprosthesis due... [+3]
Multiple valvular disease requiring surgical intervention; [+5]